
scPharmaceuticals Inc. (NASDAQ: SCPH) related to its sale to MannKind Corporation. Under the terms of the proposed transaction, scPharmaceuticals’ shareholders will receive $5.35per share in cash plus one non-tradeable contingent value right per share payable upon achieving specific regulatory and net sales milestones worth up to $1.00 in cash.